glp 1 latest news Some podiatrists are voicing concerns about a new GLP-1 side effect known as "Ozempic feet." More information on the condition is available here: https://fox59.com/news/national-world/ozempic-feet-the-latest -side-effect-among-glp-1-users-doctors-warn 📰 This Week’s GLP-1 News

Stopping semaglutide entirely leads to weight regain in the majority of cases

The full benefits of sermorelin often build over several months

These drugs bind to the GLP-1 receptor and: Lower blood sugar by increasing insulin and reducing glucagon Slow gastric emptying Reduce appetite and food cravings Support clinically significant weight loss in many people They are commonly prescribed for: Type 2 diabetes Obesity or overweight with weight-related health risks Trials suggest GLP-1 agonists can reduce body weight by around 5 to 18 per cent on average, often with improvements in blood pressure, cholesterol and other cardiometabolic markers

Other Forms: What's the Difference

Clinical Update 10/16/2025 Constipation Solutions: What Works

Efficacy of levocarnitine and alpha lipoic acid in ameliorating the decline in mitochondrial enzymes during aging